Show simple item record

dc.contributor.authorDutta, N.K.
dc.contributor.authorMazumdar, K.
dc.contributor.authorGordy, J.T.
dc.date.accessioned2020-06-30T18:46:31Z
dc.date.available2020-06-30T18:46:31Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85086686612&doi=10.1128%2fJVI.00647-20&partnerID=40&md5=e85e28354071ab089f61afadf34c4f53
dc.identifier.urihttp://hdl.handle.net/10713/13205
dc.description.abstracten_US
dc.description.urihttps://doi.org/10.1128/JVI.00647-20en_US
dc.language.isoen_USen_US
dc.publisherAmerican Society for Microbiologyen_US
dc.relation.ispartofJournal of virology
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subjectnucleocapsid proteinen_US
dc.subjectsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_US
dc.subjectvaccineen_US
dc.titleThe Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Developmenten_US
dc.typeArticleen_US
dc.identifier.doi10.1128/JVI.00647-20
dc.identifier.pmid32546606


This item appears in the following Collection(s)

Show simple item record